This page is part of the FHIR Specification (v5.0.0-ballot: FHIR R5 Ballot Preview). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B
Biomedical Research and Regulation Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Not linked to any defined compartments |
Raw Turtle (+ also see Turtle/RDF Format Specification)
Example of clinicalusedefinition
@prefix fhir: <http://hl7.org/fhir/> . @prefix owl: <http://www.w3.org/2002/07/owl#> . @prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> . @prefix xsd: <http://www.w3.org/2001/XMLSchema#> . # - resource ------------------------------------------------------------------- [a fhir:ClinicalUseDefinition; fhir:nodeRole fhir:treeRoot; fhir:Resource.id [ fhir:value "example"]; fhir:DomainResource.text [ fhir:Narrative.status [ fhir:value "generated" ]; fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: ClinicalUseDefinition</b><a name=\"example\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource ClinicalUseDefinition "example" </p></div><p><b>type</b>: contraindication</p><blockquote><p><b>contraindication</b></p><h3>DiseaseSymptomProcedures</h3><table class=\"grid\"><tr><td>-</td><td><b>Concept</b></td></tr><tr><td>*</td><td>Hepatic disease associated with coagulopathy and clinically relevant bleeding risk <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (contraindicationsasdisease-symptom-procedure#Coagulopathiesandbleedingdiatheses(exclthrombocytopenic))</span></td></tr></table><h3>Comorbidities</h3><table class=\"grid\"><tr><td>-</td><td><b>Concept</b></td></tr><tr><td>*</td><td>Hepaticdisease <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (comorbidity#Hepaticdisease)</span></td></tr></table></blockquote></div>" ]; fhir:ClinicalUseDefinition.type [ fhir:value "contraindication"]; fhir:ClinicalUseDefinition.contraindication [ fhir:ClinicalUseDefinition.contraindication.diseaseSymptomProcedure [ fhir:CodeableReference.concept [ fhir:CodeableConcept.coding [ fhir:index 0; fhir:Coding.system [ fhir:value "http://ema.europa.eu/example/contraindicationsasdisease-symptom-procedure" ]; fhir:Coding.code [ fhir:value "Coagulopathiesandbleedingdiatheses(exclthrombocytopenic)" ] ]; fhir:CodeableConcept.text [ fhir:value "Hepatic disease associated with coagulopathy and clinically relevant bleeding risk" ] ] ]; fhir:ClinicalUseDefinition.contraindication.comorbidity [ fhir:index 0; fhir:CodeableReference.concept [ fhir:CodeableConcept.coding [ fhir:index 0; fhir:Coding.system [ fhir:value "http://ema.europa.eu/example/comorbidity" ]; fhir:Coding.code [ fhir:value "Hepaticdisease" ] ] ] ] ]] . # - ontology header ------------------------------------------------------------ [a owl:Ontology; owl:imports fhir:fhir.ttl] . # -------------------------------------------------------------------------------------
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.